The systemic nature of our GSK3β modulations compared to the more targeted approaches used in the studies mentioned above may account for the differences between those reports and the lack of tideglusib effects on anxiety‐like behaviours in our studies [35, 37, 38, 39]. The gene discussed is GSK3B; the disease is Anxiety.